Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
Status:
Completed
Trial end date:
2005-09-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched
placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in
reducing drinking and smoking in patients with both nicotine and alcohol dependence.
Phase:
Phase 4
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)